The PLAC Test
is the only blood test
cleared by the FDA
to aid in assessing risk for both
coronary heart disease (CHD)
and ischemic stroke associated
with atherosclerosis.
The PLAC® Test for Lp-PLA2 is the only blood test that helps identify hidden risk for heart attack and stroke. Early detection and more aggressive treatment can help prevent these events. 
Learn more about how you can run the PLAC Test in your lab. We answer technical questions you may have about the PLAC Test and how it can be used to help assess risk for heart attack and stroke.
Learn more about your risk for stroke and cardiovascular disease prevention. Now there is a simple blood test that can help uncover and hidden risk for heart attack and stroke. Discover how the PLAC Test can help your physician assess your risk for and prevent these events. 
Join us for our next moderated webinar and Q&A session on September 21, 2010. Click here for more information. ![]()
View an on-demand webinar to learn more about Lipoprotein-associated phospholipase A2 (Lp-PLA2) ![]()
Don't miss us as these events!
National Lipid Association
Washington, DC |
August 27 - 29, 2010
European Society of Cardiology
Sweden | Aug 28 - Sept 1, 2010